Kiniksa Pharmaceuticals, Ltd.·4

Jun 8, 4:20 PM ET

Cole G Bradley 4

4 · Kiniksa Pharmaceuticals, Ltd. · Filed Jun 8, 2023

Insider Transaction Report

Form 4
Period: 2023-06-06
Transactions
  • Award

    Restricted Share Units

    2023-06-06+4,3734,373 total
    Class A Common Shares (4,373 underlying)
  • Award

    Share Option

    2023-06-06+26,23626,236 total
    Exercise: $15.19Exp: 2033-06-05Class A Common Shares (26,236 underlying)
Footnotes (3)
  • [F1]The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023.
  • [F2]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
  • [F3]The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023.

Documents

1 file
  • 4
    form4-06082023_080641.xmlPrimary